IL2 and kidney cancer: There are several clinical trials taking place to treat different types of cancer with NK cells; combinations of cryosurgery and NK-based immunotherapy for advanced kidney cancer (NCT02843607), NK cell-based immunotherapy as maintenance therapy for small-cell lung cancer (NCT03410368) or NK cells along with IL-2 following chemotherapy to treat advanced melanoma or kidney cancer (NCT00328861).